[
  {
    "ts": null,
    "headline": "Here's Why You Should Retain Integer Holdings Stock in Your Portfolio",
    "summary": "ITGR leans on R&D and MedTech scale after a solid Q3 2025, but slower product adoption and supplier reliance cloud the near-term outlook.",
    "url": "https://finnhub.io/api/news?id=fe7f649b4aa31bf2cca6c7bbdaeda42e15acf80a2dc6f8c4a8386464d2afae7c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769098080,
      "headline": "Here's Why You Should Retain Integer Holdings Stock in Your Portfolio",
      "id": 138205995,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "ITGR leans on R&D and MedTech scale after a solid Q3 2025, but slower product adoption and supplier reliance cloud the near-term outlook.",
      "url": "https://finnhub.io/api/news?id=fe7f649b4aa31bf2cca6c7bbdaeda42e15acf80a2dc6f8c4a8386464d2afae7c"
    }
  },
  {
    "ts": null,
    "headline": "BD and Ypsomed Expand Partnership to Target Growing Biologics Market",
    "summary": "BDX expands its Ypsomed partnership with a 5.5 mL Neopak XtraFlow syringe, targeting rising demand for large-volume subcutaneous self-injection.",
    "url": "https://finnhub.io/api/news?id=a0244cc1d08ca46e174b65db36f1c07dae1ca1157f40c601d0575417f0474444",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769096580,
      "headline": "BD and Ypsomed Expand Partnership to Target Growing Biologics Market",
      "id": 138205985,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "BDX expands its Ypsomed partnership with a 5.5 mL Neopak XtraFlow syringe, targeting rising demand for large-volume subcutaneous self-injection.",
      "url": "https://finnhub.io/api/news?id=a0244cc1d08ca46e174b65db36f1c07dae1ca1157f40c601d0575417f0474444"
    }
  },
  {
    "ts": null,
    "headline": "4 Medical Supply Stocks Poised to Gain in a Prospering Industry",
    "summary": "Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and ALGN.",
    "url": "https://finnhub.io/api/news?id=bd42239e4490da7aaf6efca48d3a51f5b9e3358ebb09f66fca2a304aed22ee91",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769090940,
      "headline": "4 Medical Supply Stocks Poised to Gain in a Prospering Industry",
      "id": 138204698,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and ALGN.",
      "url": "https://finnhub.io/api/news?id=bd42239e4490da7aaf6efca48d3a51f5b9e3358ebb09f66fca2a304aed22ee91"
    }
  },
  {
    "ts": null,
    "headline": "2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm",
    "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 22% gain over the past six months, beating the S&P 500 by 14.2 percentage points.",
    "url": "https://finnhub.io/api/news?id=08e97459f3c06cbd03d70d2b5d43ccaa2b71ea5611d0dffde41c6a2140878c38",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769056602,
      "headline": "2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm",
      "id": 138202455,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 22% gain over the past six months, beating the S&P 500 by 14.2 percentage points.",
      "url": "https://finnhub.io/api/news?id=08e97459f3c06cbd03d70d2b5d43ccaa2b71ea5611d0dffde41c6a2140878c38"
    }
  }
]